In 172 adults with ulcerative colitis in deep remission, stopping anti-TNF therapy failed non-inferiority versus continuing: endoscopic remission at 2 years 80% vs 96% (per-protocol, n=163). Flares occurred in 52% vs 12%; retreatment succeeded in 74% (20/27).
RCTn = 172
Berset et al. Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial